Abstract
In this issue of Blood, Walter et al demonstrate an association between heat shock protein 90 (HSP90) and spleen tyrosine kinase (SYK) as a critical upstream component in tonic BCR signaling of Burkitt lymphoma (BL). Integrity of this HSP90-SYK complex appears to be critical for maintenance of tonic BCR signaling, which keeps BL cells alive. Consequently, the authors propose HSP90 as a novel therapeutic target in BL.1.
Original language | English (US) |
---|---|
Pages (from-to) | 542-544 |
Number of pages | 3 |
Journal | Blood |
Volume | 129 |
Issue number | 5 |
DOIs |
|
State | Published - Feb 2 2017 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology